Pathology and drug action in schizophrenia: insights from molecular biology

Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications

BACKGROUND

The fronto-striatal circuits are the common neurobiological basis for neuropsychiatric disorders, including schizophrenia, Parkinson's disease, Huntington's disease, attention deficit hyperactivity disorder, obsessive-compulsive disorder, and Tourette's syndrome. Fronto-striatal circuits consist of motor circuits, associative circuits, and limbic circuits. All circuits share 2 common features. First, all fronto-striatal circuits consist of hyper direct, direct, and indirect pathways. Second, all fronto-striatal circuits are modulated by dopamine. Intracellularly, the effect of dopamine is largely mediated through the cyclic adenosine monophosphate/protein kinase A signaling cascade with an additional role for the cyclic guanosine monophosphate/protein kinase G pathway, both of which can be regulated by phosphodiesterases. Phosphodiesterases are thus a potential target for pharmacological intervention in neuropsychiatric disorders related to dopaminergic regulation of fronto-striatal circuits.

METHODS

Clinical studies of the effects of different phosphodiesterase inhibitors on cognition, affect, and motor function in relation to the fronto-striatal circuits are reviewed.

RESULTS

Several selective phosphodiesterase inhibitors have positive effects on cognition, affect, and motor function in relation to the fronto-striatal circuits.

CONCLUSION

Increased understanding of the subcellular localization and unraveling of the signalosome concept of phosphodiesterases including its function and dysfunction in the fronto-striatal circuits will contribute to the design of new specific inhibitors and enhance the potential of phosphodiesterase inhibitors as therapeutics in fronto-striatal circuits.

Entrapment of Highly Active Membrane-Bound Receptors in Macroporous Sol−Gel Derived Silica

The immobilization of membrane-associated proteins remains a challenging task. Herein, we report on the entrapment of two classes of membrane-bound receptors into sol-gel derived silica. Both nicotinic acetylcholine receptor (nAChR), a ligand-gated ion channel, and dopamine D(2Short) receptor (D2R), a G-protein coupled receptor, were entrapped into a series of sol-gel derived nanocomposite materials. In cases where the silica had a bimodal pore size distribution wherein both mesopores and macropores were present, the two receptors showed 40-80% of solution activity over periods of at least 1 month. Furthermore, the dissociation constants of entrapped nAChR and D2R for binding to known agonists and antagonists were very close to the values obtained for free receptors in solution. These results indicate that membrane-bound receptors entrapped into bimodal meso/macroporous silica should provide a useful platform for the development of bioanalytical devices such as bioaffinity columns or microarrays, which could aid in diagnosis and high-throughput drug screening.